APA (7th ed.) Citation

Geo Neul Park, Kyung Ho Lee, Ji Eun Moon, Soo Jeong Choi, Moo Yong Park, Jin Kuk Kim, & Byung Chul Yu. (2024). Efficacy and cost-effectiveness of darbepoetin alfa once every 4 weeks versus continuous erythropoietin receptor activator once every 4 weeks for anemia correction in patients with chronic kidney disease not on dialysis. The Korean Society of Nephrology.

Chicago Style (17th ed.) Citation

Geo Neul Park, Kyung Ho Lee, Ji Eun Moon, Soo Jeong Choi, Moo Yong Park, Jin Kuk Kim, and Byung Chul Yu. Efficacy and Cost-effectiveness of Darbepoetin Alfa Once Every 4 Weeks Versus Continuous Erythropoietin Receptor Activator Once Every 4 Weeks for Anemia Correction in Patients with Chronic Kidney Disease Not on Dialysis. The Korean Society of Nephrology, 2024.

MLA (9th ed.) Citation

Geo Neul Park, et al. Efficacy and Cost-effectiveness of Darbepoetin Alfa Once Every 4 Weeks Versus Continuous Erythropoietin Receptor Activator Once Every 4 Weeks for Anemia Correction in Patients with Chronic Kidney Disease Not on Dialysis. The Korean Society of Nephrology, 2024.